Related Experiment Videos
Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain
Abstract:
MPTP (N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine) is a neurotoxin that induces a parkinsonian syndrome. 3H-MPTP binds densely to substantia nigra specimens from neurologically normal brains. It binds just as densely to specimens from patients with idiopathic parkinsonism despite substantial losses of dopaminergic neurons in this disorder. These results accord with findings in animal studies that suggest that MPTP binds to an extraneuronal enzyme, monoamine oxidase, which converts it to a toxic metabolite that is actively taken up and accumulates inside dopaminergic neurons. An MPTP-like toxin has been postulated to be a possible cause of idiopathic parkinsonism. Preventing uptake and concentration could be one means of blocking the action of such a toxin.
Insights
N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine (MPTP) neurotoxin binds to brain tissue in Parkinson's disease patients. This suggests an MPTP-like toxin may cause Parkinson's, and blocking its uptake could be a treatment.
Area of Science:
- Neuroscience
- Toxicology
Background:
- N-methyl-4 phenyl-1,2,3,6 tetrahydropyridine (MPTP) is a neurotoxin that causes parkinsonian syndrome.
- Idiopathic parkinsonism involves significant dopaminergic neuron loss.
Purpose of the Study:
- To investigate the binding patterns of MPTP in brain specimens.
- To explore the potential role of MPTP-like toxins in idiopathic parkinsonism.
Main Methods:
- Radioligand binding assays using 3H-MPTP.
- Comparison of binding in substantia nigra from normal brains versus Parkinson's disease patients.
Main Results:
- 3H-MPTP demonstrated dense binding to substantia nigra specimens from both neurologically normal individuals and Parkinson's disease patients.
- Binding density was comparable despite neuronal loss in Parkinson's disease.
Conclusions:
- MPTP binding patterns suggest an extraneuronal mechanism, potentially involving monoamine oxidase.
- An MPTP-like toxin is a plausible etiological factor for idiopathic parkinsonism.
- Inhibiting toxin uptake and accumulation may offer a therapeutic strategy.